Representative Jared Moskowitz Stocks

On February 11, 2025, Representative Jared Moskowitz of US Congress acquired under $15k worth of Abbott Laboratories's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 10 other transactions of Jared Moskowitz.
2025-02-11Acquired Under $15KABT Abbott LaboratoriesInsidersVerify
2024-12-09Acquired Under $15KCVX Chevron CorpInsidersVerify
2024-08-21Acquired Under $15KCVX Chevron CorpInsidersVerify
2024-08-19Acquired Under $15KJPM JPMorgan ChaseInsidersVerify
2024-08-06Acquired Under $15KELV Elevance HealthInsidersVerify
2024-01-22Acquired Under $15KPFE Pfizer IncInsidersVerify
2023-10-12Acquired Under $15KCMI CumminsInsidersVerify
2023-05-12Acquired Under $15KKMB Kimberly ClarkInsidersVerify
2023-04-12Acquired Under $15KADI Analog DevicesInsidersVerify
2023-03-10Acquired Under $15KPFE Pfizer IncInsidersVerify
View All Elective Officials  

Risk-return Landscape of Jared Moskowitz's positions

  Expected Return   
       Risk  

Assets Rated by Market Efficiency

Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
EfficiencyMarket RiskExp ReturnPrice
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.